Investigating how kindlin-3 affects neutrophil function in inflammation
Kindlin-3 signaling in neutrophils
This study is looking at how a protein called kindlin-3 helps white blood cells called neutrophils do their job better during inflammation, which could lead to new ways to treat ongoing inflammatory conditions while protecting healthy tissues.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Versiti Wisconsin, INC. NIH-funded |
| Lab location | 1 site (Milwaukee, United States) |
| Project ID | NIH-11013352 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of kindlin-3 in neutrophils, which are key players in the body's immune response. It examines how kindlin-3 influences the recruitment of neutrophils to sites of inflammation and regulates their activity, including the production of reactive oxygen species and the formation of neutrophil extracellular traps. By exploring these mechanisms, the research aims to uncover how neutrophils can effectively combat infections while minimizing damage to healthy tissues. This could lead to new insights into managing chronic inflammatory disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from chronic inflammatory disorders or conditions involving neutrophil dysfunction.
Not a fit: Patients with acute infections that do not involve neutrophil dysfunction may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for chronic inflammatory conditions by targeting neutrophil function.
How similar studies have performed: Previous research has shown that targeting immune cell signaling pathways can lead to significant advancements in treating inflammatory diseases, suggesting potential success for this approach.
Where this research is happening
Milwaukee, United States
- Versiti Wisconsin, INC. — Milwaukee, United States (Active)
Researchers
- Principal investigator: Ma, Yan-Qing — Versiti Wisconsin, INC.
- Study coordinator: Ma, Yan-Qing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.